Am J Cardiol. 2000 Jul 1;86(1):107-10.
Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease.
Lepor NE, Gross SB, Daley WL, Samuels BA, Rizzo MJ, Luko SP, Hickey A, Buchbinder NA, Naqvi TZ.
Heart Center of Los Angeles, Los Angeles, California, USA.
PMID: 10867106 [PubMed - indexed for MEDLINE]
Publication Types:
MeSH Terms:
Substances:
Full Text Sources:
Molecular Biology Databases: